Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (201-210 of 627) with videos related to

Pageof 63
Sort By:
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmbarish Pandey, Bernard J Gersh, Darren K McGuire, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Heart (British Cardiac Society)|February 26, 2013
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trialSergio Leonardi, Adriano A M Truffa, Megan L Neely, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Pageof 63

Showing results (201-210 of 627) with videos related to

Sort By:
Pageof 63
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmbarish Pandey, Bernard J Gersh, Darren K McGuire, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Heart (British Cardiac Society)|February 26, 2013
A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trialSergio Leonardi, Adriano A M Truffa, Megan L Neely, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
Stroke|December 29, 2018
Canagliflozin and Stroke in Type 2 Diabetes MellitusZien Zhou, Richard I Lindley, Karin Rådholm, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
Pageof 63